Yongxia Zhou1, Fang Yu, Timothy Q Duong. 1. Radiology/Center for Biomedical Imaging, New York University School of Medicine, New York, New York, USA; Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Abstract
PURPOSE: To quantify and investigate the interactions between multimodal MRI/positron emission tomography (PET) imaging metrics in elderly patients with early Alzheimer's disease (AD), mild cognitive impairment (MCI) and healthy controls. MATERIALS AND METHODS: Thirteen early AD, 17 MCI patients, and 14 age-matched healthy aging controls from the Alzheimer's Disease Neuroimaging Initiative database were selected based on availability of data. Default mode network (DMN) functional connectivity and fractional amplitude of low frequency fluctuation (fALFF) were obtained for resting state functional MRI (RS-fMRI). White matter lesion load (WMLL) was quantified from MRI T2-weighted FLAIR images. Amyloid deposition with PET [(18)F]-Florbetapir tracer and metabolism of glucose by means of [(18)F]-fluoro-2-deoxyglucose (FDG) images were quantified using ratio of standard uptake values (rSUV). RESULTS: Whole-brain WMLL and amyloid deposition were significantly higher (P < 0.005) in MCI and AD patients compared with controls. RS-fMRI results showed significantly reduced (corrected P < 0.05) DMN connectivity and altered fALFF activity in both MCI and AD groups. FDG uptake results showed hypometabolism in AD and MCI patients compared with controls. Correlations (P < 0.05) were found between WMLL and amyloid load, FDG uptake and amyloid load, as well as between amyloid load (rSUV) and fALFF. CONCLUSION: Our quantitative results of four MRI and PET imaging metrics (fALFF/DMN, WMLL, amyloid, and FDG rSUV values) agree with published values. Significant correlations between MRI metrics, including WMLL/functional activity and PET amyloid load suggest the potential of MRI and PET-based biomarkers for early detection of AD.
PURPOSE: To quantify and investigate the interactions between multimodal MRI/positron emission tomography (PET) imaging metrics in elderly patients with early Alzheimer's disease (AD), mild cognitive impairment (MCI) and healthy controls. MATERIALS AND METHODS: Thirteen early AD, 17 MCI patients, and 14 age-matched healthy aging controls from the Alzheimer's Disease Neuroimaging Initiative database were selected based on availability of data. Default mode network (DMN) functional connectivity and fractional amplitude of low frequency fluctuation (fALFF) were obtained for resting state functional MRI (RS-fMRI). White matter lesion load (WMLL) was quantified from MRI T2-weighted FLAIR images. Amyloid deposition with PET [(18)F]-Florbetapir tracer and metabolism of glucose by means of [(18)F]-fluoro-2-deoxyglucose (FDG) images were quantified using ratio of standard uptake values (rSUV). RESULTS: Whole-brain WMLL and amyloid deposition were significantly higher (P < 0.005) in MCI and ADpatients compared with controls. RS-fMRI results showed significantly reduced (corrected P < 0.05) DMN connectivity and altered fALFF activity in both MCI and AD groups. FDG uptake results showed hypometabolism in AD and MCI patients compared with controls. Correlations (P < 0.05) were found between WMLL and amyloid load, FDG uptake and amyloid load, as well as between amyloid load (rSUV) and fALFF. CONCLUSION: Our quantitative results of four MRI and PET imaging metrics (fALFF/DMN, WMLL, amyloid, and FDGrSUV values) agree with published values. Significant correlations between MRI metrics, including WMLL/functional activity and PET amyloid load suggest the potential of MRI and PET-based biomarkers for early detection of AD.
Authors: Yongxia Zhou; Yvonne W Lui; Xi-Nian Zuo; Michael P Milham; Joseph Reaume; Robert I Grossman; Yulin Ge Journal: J Magn Reson Imaging Date: 2013-09-06 Impact factor: 4.813
Authors: Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun Journal: J Neurosci Date: 2005-08-24 Impact factor: 6.167
Authors: Yongxia Zhou; John H Dougherty; Karl F Hubner; Bing Bai; Rex L Cannon; R Kent Hutson Journal: Alzheimers Dement Date: 2008-07 Impact factor: 21.566
Authors: Adam M Brickman; Frank A Provenzano; Jordan Muraskin; Jennifer J Manly; Sonja Blum; Zoltan Apa; Yaakov Stern; Truman R Brown; José A Luchsinger; Richard Mayeux Journal: Arch Neurol Date: 2012-12
Authors: Abhay Moghekar; Michael Kraut; Wendy Elkins; Juan Troncoso; Alan B Zonderman; Susan M Resnick; Richard J O'Brien Journal: Alzheimers Dement Date: 2012-10 Impact factor: 21.566
Authors: Lisa T Eyler; Jeremy A Elman; Sean N Hatton; Sarah Gough; Anna K Mischel; Donald J Hagler; Carol E Franz; Anna Docherty; Christine Fennema-Notestine; Nathan Gillespie; Daniel Gustavson; Michael J Lyons; Michael C Neale; Matthew S Panizzon; Anders M Dale; William S Kremen Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472
Authors: Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski Journal: Alzheimers Dement Date: 2017-03-22 Impact factor: 21.566
Authors: Seonjoo Lee; Fawad Viqar; Molly E Zimmerman; Atul Narkhede; Giuseppe Tosto; Tammie L S Benzinger; Daniel S Marcus; Anne M Fagan; Alison Goate; Nick C Fox; Nigel J Cairns; David M Holtzman; Virginia Buckles; Bernardino Ghetti; Eric McDade; Ralph N Martins; Andrew J Saykin; Colin L Masters; John M Ringman; Natalie S Ryan; Stefan Förster; Christoph Laske; Peter R Schofield; Reisa A Sperling; Stephen Salloway; Stephen Correia; Clifford Jack; Michael Weiner; Randall J Bateman; John C Morris; Richard Mayeux; Adam M Brickman Journal: Ann Neurol Date: 2016-04-27 Impact factor: 10.422
Authors: Benjamin Meyer; Caroline Mann; Manuela Götz; Anna Gerlicher; Victor Saase; Kenneth S L Yuen; Felipe Aedo-Jury; Gabriel Gonzalez-Escamilla; Albrecht Stroh; Raffael Kalisch Journal: J Neurosci Date: 2019-05-01 Impact factor: 6.167
Authors: Harini Eavani; Mohamad Habes; Theodore D Satterthwaite; Yang An; Meng-Kang Hsieh; Nicolas Honnorat; Guray Erus; Jimit Doshi; Luigi Ferrucci; Lori L Beason-Held; Susan M Resnick; Christos Davatzikos Journal: Neurobiol Aging Date: 2018-06-15 Impact factor: 4.673